Business news from Ukraine

LEKHIM TO LAUNCH PRODUCTION OF VACCINES AGAINST COVID

The pharmaceutical company Lekhim plans to launch production of vaccines against COVID-19 in 2022, the press service of Kharkiv City Council reported.
“This is a very important project. We do not know what the situation will be in a month or two with a pandemic. And the fact that Kharkiv enterprise is going to produce a vaccine and invest about EUR 25-30 million in production is very good,” Ihor Terekhov said.
He also said that Kharkiv local authorities are now doing everything possible to prepare for a likely new wave of coronavirus: drugs, necessary medical equipment and oxygen stations are being purchased.
According to the information posted on the City Council’s website, the CoronaVac vaccine, created by the Chinese company Sinovac Biotech, will be produced in Kharkiv. In 2021, Lekhim Group became the official supplier of this vaccine in Ukraine.

, , ,

DOMESTIC PHARMACEUTICAL MANUFACTURERS IN TALKS TO LOCALIZE PRODUCTION OF INFLUENZA VACCINES IN UKRAINE

Domestic pharmaceutical manufacturers are negotiating to localize the production of influenza vaccines in Ukraine, the vaccine will be presented on the market in the first quarter of 2022, Deputy Minister of Health, Chief State Sanitary Doctor Ihor Kuzin said in an online interview with medical expert of the United Nations Children’s Fund (UNICEF) in Ukraine Kateryna Bulavinova.
“Ukrainian pharmaceutical manufacturers are negotiating to localize the production of influenza vaccines in Ukraine. It will be a tri- or quadrivalent vaccine in monodose syringes. We hope that such a vaccine will be available on the market during the first quarter of 2022,” he said.
Kuzin noted that it is also planned to purchase about 1 million doses of the vaccine.
“According to forecasts, we will have the same influenza epidemic season as last year. Since June we have been working with vaccine manufacturers and the pharmaceutical sector. Negotiations are underway to transfer a free vaccine to vaccinate health workers within the humanitarian aid framework. The amount of vaccine that will be supplied to the country for the pharmacy network will be slightly more than last year – about 1 million doses,” the deputy minister said.

, , ,

UKRAINE WANTS TO ALLOW MIXING DIFFERENT TYPES OF VACCINES

In Ukraine, they want to officially allow mixing different types of vaccines, chief sanitary doctor Ihor Kuzin said.
“The National Technical Group of Experts on Immunization, as the main advisory agency of the Health Ministry, recommended to allow the so-called mixing of the vaccine, but under strict observance of certain conditions. We are talking about the possibility of administering a second dose of Comirnaty/Pfizer-BioNTech after the first dose of Moderna’s mRNA vaccine, if it is not possible to complete the vaccination with the same medicine. Also, if a person has a severe allergic reaction to the first dose of the vector vaccine from AstraZeneca, it is allowed to administer a second dose of Comirnaty at the doctor’s discretion,” Kuzin said.
According to him, the relevant decision of the expert group has already been made. Now the issue of issuing the relevant decision and the development of detailed step-by-step instructions are being considered.

,

UKRAINE ENTERS LIST OF COUNTRIES WHICH WILL RECEIVE VACCINES FROM U.S.

The administration of U.S. President Joe Biden has presented a proposed plan for the distribution of the first 25 million doses of COVID-19 vaccines, which Ukraine will receive among others.
“Approximately 6 million will be targeted toward regional priorities and partner recipients, including Mexico, Canada, and the Republic of Korea, West Bank and Gaza, Ukraine, Kosovo, Haiti, Georgia, Egypt, Jordan, Iraq, and Yemen, as well as for United Nations frontline workers,” a message posted on the website of the White House on Thursday reads.
The White House says that the Administration announced its framework for sharing at least 80 million U.S. vaccine doses globally by the end of June and the plan for the first 25 million doses.

, ,

MINISTER: MANUFACTURERS START TO ‘CANCEL DEBTS’ ON CONTACTS FOR VACCINES AGAINST CORONAVIRUS SUPPLY

Manufacturers of vaccines against coronavirus (COVID-19) disease have begun to “cancel debts” on contacts for supplies, Health Minister Maksym Stepanov has said.
“Now the situation has begun to level out and manufacturing companies have begun to cancel the debts they owe us,” he said at a briefing on Tuesday.
Stepanov said that “in the last ten days alone, we have received 1 million doses of vaccines from the Chinese company Sinovac, deliveries have begun under the COVAX initiative – 367,000 doses of AstraZeneca vaccine and 117,000 doses of Pfizer vaccine, and in total we expect 1.4 million doses under COVAX by the end of May.”
Stepanov also expressed hope for the resumption of vaccine supplies from India.
“We expect that the embargo on the export of vaccines in India will be lifted, and that debt of 1.5 million doses of AstraZeneca vaccines that we have contracted will be closed to us,” he said.
Stepanov said that by the end of the second quarter, Ukraine expects first 500,000 doses of Pfizer vaccine, the main deliveries through this contact will begin in July, in particular, 4.5 million doses are expected in the third quarter.

,

UKRAINE AND INDIAN MANUFACTURER AGREE TO INCREASE SUPPLY OF VACCINES AGAINST CORONAVIRUS TO 15 MLN DOSES

Ukraine has agreed with the Indian manufacturer Serum Institute to increase the supply of vaccines against coronavirus (COVID-19) disease to 15 million doses, Health Minister Maksym Stepanov has said.
“During negotiations with the owner of the Serum Institute, Mr. Cyrus Poonawalla, an agreement was reached to increase the supply from 10 million to 15 million doses of vaccine,” he said at a briefing on Tuesday.
Stepanov also said that “there is a proposal from the Chinese company Sinovac.”
“We have reached an agreement with them to increase supplies and additional contracting,” he said.
Stepanov said that Ukraine currently has contacts for the supply of 42 million doses, but intends to increase the agreement to 48 million doses in 2021, which will allow 70% of the adult population to be vaccinated.

, ,